Related Experiment Video
Updated: Jan 15, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Investigating IgG Levels in Pediatrics with Kawasaki Disease and Its Association with Clinical Outcomes: A
Seyed Mehdi Aghapour1, Mousa Ghelichi-Ghojogh2, Jabbar Parhiz3
1Neonatal and Children's Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Insights
This study investigated IgG levels in Kawasaki Disease patients, finding no significant difference between sexes. Early diagnosis and treatment, including intravenous immunoglobulin (IVIG), are crucial for preventing complications in children with this vasculitis.
Area of Science:
- Pediatrics
- Immunology
- Rheumatology
Background:
- Kawasaki Disease is a critical pediatric systemic vasculitis requiring prompt aspirin and IVIG treatment.
- Early intervention is key to preventing severe complications such as coronary artery aneurysms.
Purpose of the Study:
- To examine IgG levels in pediatric patients diagnosed with Kawasaki Disease.
- To explore the correlation between IgG levels and clinical outcomes in Kawasaki Disease patients.
- To analyze demographic and clinical characteristics of Kawasaki Disease patients.
Main Methods:
- A cross-sectional study involving 36 pediatric patients with Kawasaki Disease at Taleghani Hospital.
- Patients were classified as complete or incomplete Kawasaki Disease.
- Data collected included IgG levels, clinical features, laboratory results, and echocardiograms; analyzed using t-tests and Chi-square tests.
Main Results:
- The majority of patients (63.9%) were aged 1-5 years; 89.2% showed no coronary involvement.
- A high response rate to treatment (91.7%) was observed.
- Elevated inflammatory markers (ESR, CRP) were common (72.2%); IgG levels were slightly higher in females but not significantly.
Conclusions:
- Prompt diagnosis and treatment, including IVIG, are vital for managing Kawasaki Disease and preventing complications.
- Paraclinical findings, including IgG levels, are important indicators for treatment response and patient outcomes.
Background:
Kawasaki Disease is a type of systemic vasculitis. Patients diagnosed with Kawasaki Disease require a regimen of aspirin and intravenous immunoglobulin (IVIG). Timely diagnosis and proactive treatment can prevent complications associated with Kawasaki Disease. Therefore, this study was conducted to investigate the levels of IgG in Kawasaki patients and its correlation with clinical outcomes at Taleghani Hospital in Gorgan in 2022.
Methods:
This cross-sectional study was conducted on 36 Kawasaki patients admitted to Taleghani Hospital in Gorgan in 2022. Patients were categorized into two groups based on Kawasaki criteria: complete and incomplete. Levels of IgG and primary disease characteristics, laboratory findings, and echocardiographic results were measured and recorded. Data was collected using a researcher-made checklist through observation, examination, and interview. Data were analyzed using an independent t-test and a Chi-square test at the 0.05 level, as determined by SPSS version 23.
Results:
The results showed that the average age of the children was 26.43 ± 21.88 months, with 63.9% of the samples aged between 1 and 5 years. 89.2% did not have coronary involvement, and 91.7% responded to treatment. Leukopenia was present in 2.8% of children, leukocytosis in 75%, and 36% were in the acute phase. Inflammatory factors ESR and CRP were positive in 72.2% of children. The average IgG level in female children was higher than in males, but this difference was not significant. The frequency of laboratory diagnosis was less in boys than in girls, but this difference was also not significant.
Conclusion:
Timely diagnosis and proactive treatment (IVIG) can prevent complications associated with Kawasaki Disease. Paraclinical findings play a significant role in determining the response to treatment and clinical outcomes.
More Related Videos
06:19Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Coronary Syndrome III: Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests